SkyView Investment Advisors LLC Acquires 403 Shares of Agilent Technologies, Inc. (NYSE:A)

SkyView Investment Advisors LLC increased its holdings in Agilent Technologies, Inc. (NYSE:A) by 13.3% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 3,437 shares of the medical research company’s stock after purchasing an additional 403 shares during the period. SkyView Investment Advisors LLC’s holdings in Agilent Technologies were worth $446,000 at the end of the most recent reporting period.

Other hedge funds have also recently bought and sold shares of the company. Quantbot Technologies LP bought a new position in Agilent Technologies in the 1st quarter worth approximately $938,000. Cetera Investment Advisers raised its stake in Agilent Technologies by 953.3% during the 1st quarter. Cetera Investment Advisers now owns 32,694 shares of the medical research company’s stock valued at $4,757,000 after purchasing an additional 29,590 shares during the last quarter. iA Global Asset Management Inc. raised its stake in Agilent Technologies by 26.2% during the 1st quarter. iA Global Asset Management Inc. now owns 21,770 shares of the medical research company’s stock valued at $3,168,000 after purchasing an additional 4,523 shares during the last quarter. Bayesian Capital Management LP acquired a new stake in Agilent Technologies in the 1st quarter worth $1,355,000. Finally, Nomura Holdings Inc. acquired a new stake in Agilent Technologies in the 4th quarter worth $823,000. 87.42% of the stock is owned by institutional investors and hedge funds.

Agilent Technologies Stock Up 0.9 %

Shares of A opened at $148.06 on Monday. The firm has a 50 day simple moving average of $138.91 and a two-hundred day simple moving average of $138.99. The company has a debt-to-equity ratio of 0.36, a current ratio of 1.78 and a quick ratio of 1.37. Agilent Technologies, Inc. has a one year low of $96.80 and a one year high of $155.35. The company has a market cap of $43.20 billion, a P/E ratio of 35.00, a P/E/G ratio of 6.48 and a beta of 1.05.

Agilent Technologies (NYSE:A) last released its earnings results on Wednesday, August 21st. The medical research company reported $1.32 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.26 by $0.06. Agilent Technologies had a return on equity of 25.26% and a net margin of 21.75%. The firm had revenue of $1.58 billion for the quarter, compared to analysts’ expectations of $1.56 billion. During the same quarter in the previous year, the business posted $1.43 earnings per share. The business’s revenue for the quarter was down 5.6% on a year-over-year basis. Research analysts forecast that Agilent Technologies, Inc. will post 5.24 EPS for the current fiscal year.

Agilent Technologies Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, October 23rd. Stockholders of record on Tuesday, October 1st will be issued a dividend of $0.236 per share. The ex-dividend date of this dividend is Tuesday, October 1st. This represents a $0.94 annualized dividend and a dividend yield of 0.64%. Agilent Technologies’s dividend payout ratio (DPR) is presently 22.22%.

Analyst Ratings Changes

A has been the topic of a number of research reports. Stifel Nicolaus restated a “buy” rating and set a $151.00 price objective on shares of Agilent Technologies in a research report on Monday, August 26th. Evercore ISI increased their price objective on shares of Agilent Technologies from $130.00 to $135.00 and gave the company an “in-line” rating in a research note on Thursday, August 22nd. Wolfe Research lowered shares of Agilent Technologies from an “outperform” rating to a “peer perform” rating in a research report on Thursday, June 27th. Barclays upped their target price on shares of Agilent Technologies from $125.00 to $135.00 and gave the company an “underweight” rating in a research note on Friday, August 23rd. Finally, TD Cowen raised their price target on shares of Agilent Technologies from $153.00 to $160.00 and gave the stock a “buy” rating in a research note on Thursday, August 22nd. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and nine have issued a buy rating to the stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $142.93.

Insider Activity at Agilent Technologies

In other news, SVP Dominique Grau sold 9,990 shares of the business’s stock in a transaction dated Thursday, September 26th. The stock was sold at an average price of $145.00, for a total transaction of $1,448,550.00. Following the sale, the senior vice president now directly owns 40,011 shares in the company, valued at $5,801,595. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. In other news, SVP Dominique Grau sold 9,990 shares of Agilent Technologies stock in a transaction on Thursday, September 26th. The shares were sold at an average price of $145.00, for a total transaction of $1,448,550.00. Following the transaction, the senior vice president now owns 40,011 shares in the company, valued at $5,801,595. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CEO Padraig Mcdonnell sold 1,958 shares of the business’s stock in a transaction on Thursday, August 22nd. The stock was sold at an average price of $145.00, for a total transaction of $283,910.00. Following the completion of the sale, the chief executive officer now directly owns 24,118 shares in the company, valued at approximately $3,497,110. The disclosure for this sale can be found here. Insiders have sold a total of 13,906 shares of company stock valued at $2,006,580 in the last 90 days. 0.33% of the stock is owned by corporate insiders.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.